Evaluation of Abbott anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA assays in a clinical lab.

Authors:
Manalac J; Yee J; Calayag K; Nguyen L; Patel PM and 2 more

Journal:
Clin Chim Acta

Publication Year: 2020

DOI:
10.1016/j.cca.2020.09.002

PMCID:
PMC7476889

PMID:
32910980

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Chim Acta

Abbreviation: Clin Chim Acta

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Chemistry, Clinical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid…
Wu Z; Yang C; Shen Y and 17 more (2023) - Transparency Score: 4/6
A 14+7 day quarantine period and a dual nucleic acid testing reagent strategy detect potentially in…
Wang YJ; Xue JH; Fang ZX and 4 more (2022) - Transparency Score: 3/6
A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech p…
Hubacek JA; Philipp T; Adamkova V and 2 more (2022) - Transparency Score: 3/6
Angiotensin-converting enzyme 1 and voltage-gated potassium channel-interacting protein 4 gene poly…
Abbaszadeh H; Mohammadi F; Rajabi-Moghaddam M and 4 more (2022) - Transparency Score: 3/6
At-admission HbA<sub>1c</sub> levels in hospitalized COVID-19 participants with and without known d…
Valle A; Rodriguez J; Camiña F and 3 more (2022) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025